Farnesol biosynthesis in Candida albicans: Cellular response to sterol inhibition by zaragozic acid B

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2366-2369

  Hornby, Jacob M ^a   Kebaara, Bessie W ^a   Nickerson, Kenneth W ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; ANTIFUNGAL AGENT; FARNESOL; FARNESYL DIPHOSPHATE; SQUALENE SYNTHASE INHIBITOR; STEROL; UNCLASSIFIED DRUG; ZARAGOZIC ACID A; ZARAGOZIC ACID B;

ARTICLE; BIOFILM; BIOSYNTHESIS; CANDIDA ALBICANS; CELLULAR IMMUNITY; DRUG INHIBITION; ENZYME ACTIVITY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; HOSPITAL INFECTION; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; STEROL SYNTHESIS;

ANTIFUNGAL AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CANDIDA ALBICANS; FARNESOL; STEROLS;

EID: 0038650921     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2366-2369.2003     Document Type: Article

References (16)

1. Bansal, V. S., and S. Vaidya. 1994. Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes. Arch. Biochem. Biophys. 315:393-399.
2. Bergstrom, J. D., C. Dufresne, G. F. Bills, M. Nallin-Omstead, and K. Byrne. 1995. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. Annu. Rev. Microbiol. 49:607-639.
3. Bostedor, R. G., J. D. Karkas, B. H. Arison, V. S. Bansal, S. Vaidya, J. I. Germershausen, M. M. Kurtz, and J. D. Bergstrom. 1997. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. J. Biol. Chem. 272:9197-9203.
4. Filler, S. G., and B. J. Kullberg. 2002. Deep-seated Candidal infections, p. 341-348. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
5. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. D. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
6. Kullberg, B. J., and S. G. Filler. 2002. Candidemia, p. 327-340. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
7. Lo, H. J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
8. Machida, K., T. Tanaka, K.-I. Fujita, and M. Tanaguchi. 1998. Farnesol-induced generation of reactive oxygen species via indirect inhibition of the mitochondrial electron transport chain in the yeast Saccharomyces cerevisiae. J. Bacteriol. 180:4460-4465.
9. Machida, K., T. Tanaka, Y. Yano, S. Otani, and M. Taniguchi. 1999. Farnesol-induced growth inhibition in Saccharomyces cerevisiae by a cell cycle mechanism. Microbiology 145:293-299.
10. Nickerson, W. J. 1947. Biology of pathogenic fungi. Chronica Botanica Company, Waltham, Mass.
11. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, England.
12. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
13. 2+ channels in vascular smooth muscle cells. J. Biol. Chem. 272:32240-32246.
14. Taylor, F. R., R. J. Rodriguez, and L. W. Parks. 1983. Relationship between antifungal activity and inhibition of sterol biosynthesis in miconazole, clotrimazole, and 15-azasterol. Antimicrob. Agents Chemother. 23:515-521.
15. Vaidya, S., R. Bostedor, M. M. Kurtz, J. D. Bergstrom, and V. S. Bansal. 1998. Massive production of farnesol-derived dicarboxylic acids in mice treated with squalene synthase inhibitor zaragozic acid B. Arch. Biochem. Biophys. 355:84-92.
16. Voziyan, P. A., J. S. Haug, and G. Melnykovych. 1995. Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol induced apoptotic cell death. Biochem. Biophys. Res. Commun. 212:479-486.